Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Schultz

Showing results (261-270 of 278) with videos related to

Pageof 28
Sort By:
Advances in Enzyme Regulation|June 1, 2000
An assessment of the antithymine and antipurine characteristics of MTA (LY231514) in CCRF-CEM cellsV J Chen, J R Bewley, P G Smith, et al.
Anticancer Research|July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmanninR M Schultz, R L Merriman, S L Andis, et al.
Journal of Veterinary Internal Medicine|March 27, 2010
Salmon poisoning disease in dogs: 29 casesJ E Sykes, S L Marks, S Mapes, et al.
Cancer Research|February 15, 1994
A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumorsL L Habeck, T A Leitner, K A Shackelford, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine regionC Shih, L S Gossett, J M Gruber, et al.
Journal of Leukocyte Biology|December 1, 1986
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophagesS W Russell, J L Pace, L Varesio, et al.
British Journal of Cancer|August 26, 1998
Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cellsV J Chen, J R Bewley, S L Andis, et al.
Seminars in Oncology|December 22, 1999
Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cellsV J Chen, J R Bewley, S L Andis, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Journal of Medicinal Chemistry|March 1, 1996
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogsB H Norman, C Shih, J E Toth, et al.
Pageof 28

Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Advances in Enzyme Regulation|June 1, 2000
An assessment of the antithymine and antipurine characteristics of MTA (LY231514) in CCRF-CEM cellsV J Chen, J R Bewley, P G Smith, et al.
Anticancer Research|July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmanninR M Schultz, R L Merriman, S L Andis, et al.
Journal of Veterinary Internal Medicine|March 27, 2010
Salmon poisoning disease in dogs: 29 casesJ E Sykes, S L Marks, S Mapes, et al.
Cancer Research|February 15, 1994
A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumorsL L Habeck, T A Leitner, K A Shackelford, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine regionC Shih, L S Gossett, J M Gruber, et al.
Journal of Leukocyte Biology|December 1, 1986
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophagesS W Russell, J L Pace, L Varesio, et al.
British Journal of Cancer|August 26, 1998
Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cellsV J Chen, J R Bewley, S L Andis, et al.
Seminars in Oncology|December 22, 1999
Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cellsV J Chen, J R Bewley, S L Andis, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Journal of Medicinal Chemistry|March 1, 1996
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogsB H Norman, C Shih, J E Toth, et al.
Pageof 28